Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13

Completed · Phase 2

Conditions studied: Opioid-Related Disorders

In brief

The purpose of this study is to evaluate buprenorphine and behavioral treatment with and without contingent payment on compliance with pro-social activities. In addition, we will examine whether blind naltrexone dosing is effective in indicating naltrexone consumption.

Key facts

Study ID

NCT00000231

Run by

National Institute on Drug Abuse (NIDA)

People needed

0

Starts

1992-02-01

Last updated by the study team

2005-08-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Treatment Research Center — Burlington, Vermont, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.